1-1 of 1
Erika Rudnicki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-in-human, open-label, Phase 1 study of a novel CD30-directed antibody-drug conjugate with a topoisomerase 1 inhibitor payload, PF-08046044 (35C), in patients with Relapsed/Refractory lymphomas: Updated safety, PK, preliminary efficacy and ctdna analysis from dose escalation

Free
Swetha Thiruvengadam, Christina Poh, Ryan Lynch, Craig Moskowitz, Michael Spinner, Martin Hutchings, Cristina García Herce, Elizabeth Phillips, Aung Tun, Julie Vose, Mina Nayeri, Erika Rudnicki, Maria Delioukina, Michelle Fanale, Sujit Biswas, Hailing Lu, Carlo Visco
Journal: Blood
Blood (2025) 146 (Supplement 1): 155.
https://doi.org/10.1182/blood-2025-155
Published: 2025